Did ADMS stock beat earnings estimates in the most recent quarter?
Adamas Pharmaceuticals Inc (ADMS) missed EPS estimates and beat revenue estimates in the most recent quarter.

NASDAQ:ADMS
Past quarterly earnings results for Adamas Pharmaceuticals Inc (ADMS), including EPS and revenue actuals, analyst estimates, and surprise percentages. This page focuses on historical performance (not forecasts).
EPS & Revenue History (in ): Actual vs estimated values, surprises, q2q growth and acceleration numbers quarterly history.
| Quarter | EPS | EPS Est | EPS Surprise | EPS Q2Q | Revenue | Revenue Est | Revenue Surprise | Revenue Q2Q |
|---|---|---|---|---|---|---|---|---|
| Q3 2021 | -0.23 | - | 45.49% | 25.896M | 25.263M | 2.50% | 28.33% | |
| Q2 2021 | -0.27 | -0.30 | 9.76% | 27.03% | 21.972M | 22.382M | -1.83% | 16.93% |
| Q1 2021 | -0.36 | -0.52 | 30.80% | 38.98% | 19.31M | 20.417M | -5.42% | 33.36% |
| Q4 2020 | -0.64 | -0.52 | -21.97% | - | 21.01M | 21.375M | -1.71% | - |
| Q3 2020 | -0.42 | -0.49 | 14.41% | - | 20.18M | 21.367M | -5.55% | - |
| Q2 2020 | -0.37 | -0.62 | 40.56% | - | 18.79M | 15.625M | 20.26% | - |
| Q1 2020 | -0.59 | -0.79 | 25.00% | - | 14.48M | 15.434M | -6.18% | - |
Notes
Adamas Pharmaceuticals Inc (ADMS) missed EPS estimates and beat revenue estimates in the most recent quarter.